Top 20 Companies in Losartan Potassium Tablets Market 2025: Strategic Overview And Future Trends (2024–2035)
RELEASE DATE: Oct 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Losartan Potassium Tablets Market Size is projected to Grow from USD 2.66 Billion in 2024 to USD 5.21 Billion by 2035, at a CAGR of 6.3% during the forecast period 2025–2035. The market for Losartan Potassium Tablets is growing demand due to the increasing incidence of cardiovascular diseases and hypertension, rising awareness regarding the treatment modalities, and availability of generic versions. Further, government healthcare policies that support such initiatives and improvements in drug delivery systems also lead to increasing patient accessibility and market growth.
Introduction
The losartan potassium tablets business refers to the production and distribution of losartan potassium, an angiotensin II receptor antagonist (ARA) or ARB, used extensively in the management of hypertension, prevention of stroke, and treatment of chronic kidney disease and heart failure. Losartan potassium tablets lower blood pressure and cardiovascular disease risk by lowering the tension in the arteries. The increasing incidence of hypertension and cardiovascular disorders worldwide is one of the key drivers for market growth, as physicians are prescribing losartan in increasing numbers due to its safety and efficacy. Moreover, increased awareness of controlling hypertension and increasing the population of geriatric people also requires losartan potassium tablets. Growth opportunities in the market are further boosted by continuous research to formulate better drugs with high bioavailability and minimal side effects. For this purpose, the growing application of the generic form of losartan has priced the drug cheaper, once again boosting market penetration, especially in developing economies. Large pharmaceutical firms such as Merck, Cipla, Sun Pharma, and Teva Pharmaceuticals stock the market with large-scale manufacturing outlets and channels, making the market a stocked one, such that the drug is readily available everywhere. In March 2025, Arbli, a ready-to-use liquid losartan potassium formulation, was approved by the U.S. FDA, providing consistent dosing without tablet crushing, safe, and convenient. It has an 18-month shelf life at room temperature, addressing the needs of patients in need of liquid medication.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the Losartan Potassium Tablets Market.
Losartan Potassium Tablets Market Size & Statistics
- The Market Size for Losartan Potassium Tablets Was estimated to be worth USD 2.66 Billion in 2024.
- The Market size is going to Expand at a CAGR of 6.3% between 2025 and 2035.
- The Global Losartan Potassium Tablets Market Size is anticipated to reach USD 5.21 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Losartan Potassium Tablets Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Losartan Potassium Tablets Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Losartan Potassium Tablets market.
Asia Pacific is expected to grow at the fastest CAGR in the losartan potassium tablets market during the forecast period. The Asia Pacific is rapidly growing in the losartan potassium tablets market based on the growing population of the region, rising incidence of hypertension and cardiovascular ailments, and the growing geriatric population, base strongly propels demand. Growing healthcare awareness levels and enhanced healthcare infrastructure further fuel market growth. Furthermore, rising government support and supportive regulatory guidelines also encourage increased access to affordable drugs. The presence of up and coming economies such as India and China with growing pharmaceutical manufacturing capabilities is also supportive. Increasing expenditure on research and development, along with rising disposable incomes, improves the market growth potential in the region.
North America is expected to generate the highest demand during the forecast period in the Losartan Potassium Tablets market.
North America is dominating the global market for losartan potassium tablets, owing to its advanced healthcare infrastructure and high incidence of hypertension and cardiovascular diseases. The region is also supported by a strong government support system, global awareness of hypertension control, and major pharma companies investing significantly in research and development. Nearly half of the adults residing in the United States have hypertension, as reported by the Centers for Disease Control and Prevention (CDC), which emphasizes the heavy need for drugs that treat hypertension, such as Losartan.
Top 7 Trends in the Losartan Potassium Tablets Market
- Growing demand driven by aging populations and hypertension
- Shift towards fixed-dose combination (FDC) therapies
- Increased development of advanced formulations
- Continued growth of the generic market
- Emphasis on drug safety and quality assurance
- Expansion of online and telehealth distribution channels
- Regional market shifts
1. Growing demand driven by aging populations and hypertension
The global rise in both the elderly population and the prevalence of hypertension is the primary driver of market growth. As the number of people with high blood pressure and other cardiovascular diseases increases, so does the demand for effective treatments like losartan.
2. Shift towards fixed-dose combination (FDC) therapies
There is a growing preference for FDC therapies that combine losartan with other antihypertensive agents, such as hydrochlorothiazide (HCTZ) or amlodipine. These combinations improve patient adherence by simplifying treatment regimens for those with multiple conditions and offer multi-mechanism blood pressure control.
3. Increased development of advanced formulations
To enhance patient convenience and therapeutic effectiveness, companies are developing innovative formulations beyond standard tablets. Examples include extended-release tablets, orally disintegrating tablets for patients who have trouble swallowing, and ready-to-use oral suspensions.
4. Continued growth of the generic market
Following the expiration of patents, affordable generic formulations of losartan continue to expand market access, especially in developing regions. This intensifies competition among manufacturers, driving down prices and fueling the need for product differentiation.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Losartan Potassium Tablets market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 7 Companies Leading the Losartan Potassium Tablets Market
- Merck & Co.
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Aurobindo Pharma
- Lupin
- Torrent Pharmaceuticals.
- Others
1. Merck & Co.
Headquarters: U.S.
Merck & Co., Inc. developed and originally marketed losartan potassium tablets under the brand name Cozaar. The company lost its market exclusivity in 2010 when the patent expired, paving the way for generic versions that now dominate the market.
2. Teva Pharmaceutical Industries
Headquarters: Israel
Teva Pharmaceutical Industries is a major manufacturer and distributor of generic Losartan Potassium tablets, a widely used medication for high blood pressure and other conditions, and was a significant player in the 2019 recall of certain lots due to NMBA impurity concerns. Despite past issues, Teva continues to be a key supplier in the competitive generic Losartan market, benefiting from the drug's expired patent and contributing to the market's growth through large-scale manufacturing.
3. Sun Pharmaceutical Industries
Headquarters: Mumbai
Sun Pharmaceutical Industries is a major manufacturer and distributor of Losartan Potassium tablets, offering their generic brand, Repace, and other formulations in the Indian and global markets. Their participation is characterized by large-scale manufacturing, extensive product offerings of losartan and combination products like Repalol H, and a strong presence through general medicine platforms.
4. Dr. Reddy’s Laboratories
Headquarters: Hyderabad
Dr. Reddy's Laboratories is a major global manufacturer and supplier of Losartan Potassium API (Active Pharmaceutical Ingredient), a key component for Losartan Potassium tablets, and also supplies the finished dosage form to various markets including the US, Europe, and emerging economies. The company leverages its expertise in API development, regulatory affairs, and its global supply chain to be a significant player in the growing Losartan Potassium tablets market, which is driven by rising hypertension rates and demand for affordable generics.
Are you ready to discover more about the Losartan Potassium Tablets market?
The report provides an in-depth analysis of the leading companies operating in the global Losartan Potassium Tablets market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Merck & Co.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Aurobindo Pharma
- Lupin
- Torrent Pharmaceuticals
- Others
Conclusion
The Losartan Potassium Tablets business is positioned for significant future expansion, driven by global demographic and health trends. The increasing need to manage hypertension and cardiovascular ailments in an aging worldwide population is the primary engine of demand. Market growth is further bolstered by the widespread availability of more affordable generic versions and continuous innovations, such as the introduction of fixed-dose combination therapies and advanced drug formulations designed to improve patient adherence and convenience. While North America currently leads in overall demand due to its advanced healthcare systems and high prevalence of the disease, the Asia Pacific region is forecast to experience the fastest growth, fueled by its immense and growing population base, improved healthcare infrastructure, and rising awareness. This competitive landscape is populated by major global pharmaceutical manufacturers who are investing in both large-scale production and research and development to maintain their standing in the evolving market.
Brower Related Report:
Global Sneakers Market Size To Exceed USD 139.12 Billion by 2033: Industry Report
Global Aerospace Nanotechnology Market Size to Exceed USD 7.54 Billion by 2033: Market Insight Report
Global Free Space Optics Communication Market Size to Exceed USD 21.11 Billion by 2033: Market Insight Report
Global Cerium Oxide Nanoparticles Market Size to worth USD 1663.8 Million by 2033: Market Insight Report
Global Data Center Chip Market Size to worth USD 41.5 Billion by 2033: Market Statistics Report
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?